Validation and Adjustment of the Leipzig-Halifax Acute Aortic Dissection Type A Scorecard

Hanna Mejàre-Berggren1, Christian Olsson1

  • 1Department of Molecular Medicine and Surgery, Cardiovascular Surgery Unit, The Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.

Insights

The Leipzig-Halifax (LH) scorecard for acute aortic dissection type A (AADA) was validated and improved by including Penn class non-Aa, enhancing its prognostic performance for in-hospital death prediction.

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Aortic Surgery

Background:

  • The Leipzig-Halifax (LH) scorecard is a risk stratification tool for acute aortic dissection type A (AADA).
  • It predicts in-hospital mortality based on age, malperfusion, critical state, and coronary disease.
  • External validation is crucial to assess and potentially refine its performance.

Purpose of the Study:

  • To externally validate the performance of the Leipzig-Halifax (LH) scorecard for acute aortic dissection type A (AADA).
  • To propose adjustments to the LH scorecard to improve its prognostic accuracy if validation indicates inadequacy.

Main Methods:

  • External validation cohort of 509 consecutive AADA patients operated on between 1996 and 2016.
  • Univariable and multivariable analyses identified predictors of in-hospital death.
  • LH scorecard applied to the validation cohort; variable selection adjusted based on discrimination and calibration measures.

Main Results:

  • In-hospital mortality was 17.7%. Critical preoperative state and Penn class non-Aa were independent predictors of death.
  • An adjusted scorecard including Penn class non-Aa, critical preoperative state, and coronary disease showed improved discrimination (AUC 0.66 vs. 0.61) and calibration (goodness-of-fit p=0.86 vs. 0.01).
  • The adjusted scorecard demonstrated better risk stratification across low, medium, and high-risk groups.

Conclusions:

  • External validation and subsequent adjustment of the LH scorecard improved its prognostic performance.
  • The refined LH scorecard shows potential as a valuable tool for risk prediction in AADA patients.
  • Further validation is recommended to solidify its clinical utility.
Abstract

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
408
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
387
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
356
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
499